Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home

Armando Zuniga

CSO

Shape Biopharmaceuticals

Au ZH, Switzerland

10 profile visits

Co-founder and CSO of Shape Biopharmaceuticals. Dedicated to science since more than 25 years in the fields of vaccine development and active immunotherapy.

My organisation

Shape Biopharmaceuticals AG develops multi-target antibody-inducing immunotherapies using its fully synthetic SHAPEnano nanoparticle platform. The technology enables durable modulation of multiple pathways with ultra-low dosing and scalable peptide-like manufacturing. Our lead program targets PCSK9 and ANGPTL pathways for mixed hyperlipidemia, with in vivo proof-of-concept showing combined cholesterol and triglyceride lowering. We are advancing toward clinical candidate nomination and seek partners for R&D, EU projects, and translational development.
Read more

About me

Social media